Profile of St. Jude Medical’s Allure Quadra quadripolar pacemaker system for cardiac resynchronization therapy

References

• Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994;72:S3-9
   PubMedGoogle Scholar
• Anonymous Mortality from congestive heart failure-United States, 19861990. MMWR 1994
   Google Scholar
• American Heart Association. 1999 Heart and Stroke Statistic Update, Dallas, Tex: American Heart Association. 1998
   Google Scholar
• Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997;45(8):968-74
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215
   PubMed Web of Science ®Google Scholar
• Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12
   PubMed Web of Science ®Google Scholar
• Mark D. Economics of treating heart failure. Am J Cardiology 1997;80:33H-8H
   Google Scholar
• Fisher ES, Wennberg JE, Stuker TA, et al. Hospital readmissions rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med 1994;331:989-95
   PubMed Web of Science ®Google Scholar
• Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States 1973-1986: evidence for increasing population prevalence. Arch Intern Med 1990;150:769-73
   PubMed Web of Science ®Google Scholar
• Anderson GF, Steinberg EP. Hospital re-admissions in the Medicare population. N Engl JMed 1984;311:1349-53
   PubMed Web of Science ®Google Scholar
• Jenks S, Williams M, Coleman E. Re-hospitalizations among patients in the Medicare fee for service Program N Engl J Med. 2009;360:1418-28
   Google Scholar
• Croft JB, Giles WH, Pollard RA, et al. Heart failure survival among older adults in the United States: A poor prognosis for an emerging epidemic
   Google Scholar
• McKinnon ME, McKee CM. Heart failure: The Cinderella of cardiology’? Public Health 1996;I 10:351-5
   Google Scholar
• Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998;352(Suppl I):3-7
   PubMed Web of Science ®Google Scholar
• HFSA 2010 Comprehensive heart failure practice guideline. J Card Fail 2010;16(6):475-539
   Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10(10):933-89
   PubMed Web of Science ®Google Scholar
• Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused Update for the 2008 Guidelines for Device based Therapy for Cardiac Rhythm Abnormalities Report from the AHA Task force on Practice Guidelines. Am Coll Cardiol 2012;60(14):1297-313
   PubMed Web of Science ®Google Scholar
• Paparella G, Sciarra L, Capulzini L, et al. Long-Term Effects of Upgrading to Biventricular Pacing: Differences with Cardiac Resynchronization Therapy as Primary Indication. Pacing Clin Electrophysiol 2010;33(7):841-9
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart failure. N Engl J Med 2005;352:1539-49
   PubMed Web of Science ®Google Scholar
• Anand IS, Carson P, Galle E, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation 2009;119:969-77
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CAREHF) Study Investigators: the effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350(21):2140-50
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53
   PubMed Web of Science ®Google Scholar
• Tang AS, Wells A, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95
   PubMed Web of Science ®Google Scholar
• Funk M, Krumholz H. Epidemiologic and economic impact of advanced heart failure. J Cardiovasc Nurs 1996;10:1-10
   PubMedGoogle Scholar
• Wolinsky FD, Smith DM, Stump TE, et al. The sequelae of hospitalization for congestive heart failure in older adults. J Am Geriatric Soc 1997;45:558-63
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104
   PubMed Web of Science ®Google Scholar
• Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatric Soc 1997;45:968-74
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215
   PubMed Web of Science ®Google Scholar
• Russo MJ, Gelijns AC, Stevenson LW, et al. The cost of medical management in advanced heart failure during the final two years of life. J Card Fail 2008;14:651-8
   PubMed Web of Science ®Google Scholar
• Pacemakers and cardiac resynchronization therapy pacemakers (CRT-P) - global pipeline analysis, competitive landscape and market forecasts to 2017. Available from: http://store.globaldata.com/market-reports/medical-devices/pacemakers-and-cardiac-resynchronization-therapy-pacemakers-(crt-p)-global-pipeline-analysis-competitive-landscape-and-market/figures
   Google Scholar
• European Heart Rhythm Association EHRA White Book: Statistics on the use of cardiac electronic devices and electrophysiological procedures in the ESC 54 counties. Europace 2012;14: iii1–55
   Web of Science ®Google Scholar
• Curtis AB, Yancy CW, Albert NM, et al. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J 2009;158:956-64
   PubMed Web of Science ®Google Scholar
• Millennium Research Group. Available from: www.marketresearch.com/Millennium-Research-Group-v648/
   Google Scholar
• Daoud EG, Kalbfleisch SJ, Hummel JD, et al. Implantation techniques and chronic lead parameters of biventricular pacing dual chamber defibrillators. J Cardiovasc Electrophysiol 2002;13:964-70
   PubMed Web of Science ®Google Scholar
• Bisch L, Da Costa A, Dauphinot V, et al. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy. Europace 2010;12:1141-8
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intra-ventricular conduction delay. N Engl J Med 2001;344:873-80
   PubMed Web of Science ®Google Scholar
• Biffi M, Moschini C, Bertini M, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402-10
   PubMed Web of Science ®Google Scholar
• Gurevitz O, Nof E, Carasso S, et al. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005;28:1255-9
   PubMed Web of Science ®Google Scholar
• Seifert M, Schau T, Moeller V, et al. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace 2010;12:961-7
   PubMed Web of Science ®Google Scholar
• Turakhia MP, Gold M, Fischer A, et al. Decreased rate of LV lead deactivation and replacement associated with use of Quadripolar LV lead. Europace 2013;15(suppl 2):ii46:450
   Google Scholar
• Singh J, DPhil DF, Heist K. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy Heart Rhythm. 2006;3:1285-92
   Google Scholar
• Gold MR, Birgersdotter-Green U, Singh JP, et al. The relationship between ventricular electrical delay and left ventricular remodeling with CRT. Eur Heart J 2011;32:2516-42
   PubMed Web of Science ®Google Scholar
• CRTP Clinical trial CRT implant strategy using the longest electrical delay for non-left bundle branch block Patients. Available from: http://clinicaltrialsgov ClinicalTrials.gov.Identifier NCT01983293
   Google Scholar
• Mapping of the coronary venous system in patients with heart failure presenting for CRT-D (Cardiac Resynchronization Therapy) implantation. correlating QLV interval to fluoroscopic LV (Left Ventricular) lead position. Available from: http://clinicaltrials.gov/show/NCT02166762
   Google Scholar
• Pappone C, Calovic Z, Cuko A, et al. Left ventricular pacing from a site with late electrical activation improves hemodynamic response to CRT. Oct 2012 632 SAT-B-07
   Google Scholar
• Zarko C, et al. left ventricular pacing from a site of late electrical activation improves acute hemodynamic response to biventricular pacing in patients with conduction delay greater than ten milliseconds in a quadripolar left ventricular lead 19 heart rhythm. 2013
   Google Scholar
• Poole JE, Gleva MJ, Mela T, et al. Cardioverter-defibrillator generator replacements and upgrade procedures complication rates associated with pacemaker or implantable CIRC. 2010;122:1553-61
   Google Scholar
• Corbisiero R, Armbruster RA, Muller DR. Reduced costs post CRT with quadripolar LV leads compared to bipolar LV leads. HRS 2014 Poster PO01-195
   Google Scholar
• Forleo G, et al. hospitalization rates and associated cost analysis of quadripolar versus bipolar CRT-D: a comparative analysis of a single-center prospective Italian registry. HRS 2014 Oral Presentation AB39-02
   Google Scholar
• Graham C, et al. Comparison of Healthcare Utilization and Hospital Costs for Quadripolar versus Bipolar LV Lead Technologies. HRS 2014 presentation AB39-03
   Google Scholar
• Medtronic. Available from: www.medtronic.com/for-healthcare-professionals/products-therapies/cardiac-rhythm/cardiac-resynchronization-therapy-devices/consulta-cardiac-resyncrhonization-therapy-pacemaker-crt-p/#tab6
   Google Scholar
• Bostonscientific. Available from: www.bostonscientific.com/templatedata/imports/Microsite/cardiac-rhythm-resources/downloads/CRM/spec-INVIVE-US-43806.pdf
   Google Scholar
• Biotronik. Available from: www.biotronik.com/files/59417A9ACAD28625C12579ED00360924/$ FILE/BIOTRONIK_Evia%20Fact%20Sheet_EN_final.pdf
   Google Scholar
• Sorin Group. Available from: www.sorin.com/press-release/sorin-group-innovates-hemodynamic-management-heart-failure-european-introduction-its-new-generation-cardiac-resynchronization
   Google Scholar
• Forleo G, Della Rocca D, Papavasileiou L, et al. Left ventricular pacing with a new quadripolar transvenous lead for CRT: Early results of a prospective comparison with conventional implant outcomes. Heart Rhythm 2011;8(1):31-7
   PubMed Web of Science ®Google Scholar
• Hussain M, Bharma-Ariza P, Jacques A, et al. Benefits of a Quadripolar Left Ventricular Lead in Patients Undergoing Cardiac Resynchronization Therapy with Underlying Myocardial Scar. Pacing Clin Electrophysiol 2013;36(2):e45-7
   Web of Science ®Google Scholar
• Shetty A, Duckett S, Bostock J, et al. Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy. Europace 2011;13(7):992-6
   PubMed Web of Science ®Google Scholar
• Beshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461-71
   PubMed Web of Science ®Google Scholar
• Ruschitzka F, Abraham W, Singh J, et al. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex. N Engl J Med 2013;369:1395-405
   PubMed Web of Science ®Google Scholar
• Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243-50
   PubMed Web of Science ®Google Scholar
• Vatankulu MA, Goktekin O, Kaya MG, et al. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices. Am J Cardiol 2009;103:1280-4
   PubMed Web of Science ®Google Scholar
• Paparella G, Sciarra L, Capulzini L, et al. Long-term effects of upgrading to biventricular pacing: differences with cardiac resynchronization therapy as primary indication. Pacing Clin Electrophysiol 2010;33:841-9
   PubMed Web of Science ®Google Scholar
• Van Geldorp IE, Vernooy K, Delhaas T, et al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace 2010;12:223-9
   PubMed Web of Science ®Google Scholar
• Van Bommel RJ, Gorcsan J3rd, Chung ES, et al. Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS complex enrolled in PROSPECT. Heart 2010;96:1107-13
   PubMed Web of Science ®Google Scholar
• Wein S, Voskoboinik A, Wein L, et al. Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York Heart Association class II, and narrow QRS heart failure patients. J Card Fail 2010;16:432-8
   PubMed Web of Science ®Google Scholar
• Curtis A, Worley S, Adamson P, et al. Biventricular pacing for AV block and Systolic Dysfunction. N Engl J Med 2013;368:1585-93
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Sack S, et al. Long term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and conduction delay. J Am Coll Cardiol 2002;39(12):2026-33
   PubMed Web of Science ®Google Scholar
• Tanawuttiwat T, Cheng A. Which patients with AV block should receive CRT pacing. Curr Treat Options Cardiovasc Med 2014;16:291
   PubMedGoogle Scholar
• Al-Majed NS, McAlister FA, Bakal JA, et al. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-12
   PubMed Web of Science ®Google Scholar
• Calovic Z, Pappone C, Cuko A, et al. Improvement in 3-month Echocardiographic Response with Multisite Left Ventricular Pacing in Cardiac Resynchronization Therapy Patients. 2014. HRS:PO02-24
   Google Scholar
• Reddy V, Knops R, Sperzel J, et al. Permanent Leadless Cardiac Pacing: Results of the LEADLESS Trial. Circulation 2014;129(14):1466-71
   PubMed Web of Science ®Google Scholar
• ALternate Site Cardiac ReSYNChronization (ALSYNC) Study. Available from: http://clinicaltrials.gov/ct2/show/NCT01277783?term=Alternate+Site+Cardiac+Resynchronization&rank=1
   Google Scholar